Rockwell Medical (RMTI) EVP granted 15,000 RSUs after 1-for-10 reverse split
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TIMMINS MEGAN C. reported acquisition or exercise transactions in this Form 4 filing.
ROCKWELL MEDICAL, INC. executive Megan C. Timmins, EVP, CLO & Secretary, received a grant of 15,000 shares of common stock as restricted stock units at no cash cost. These RSUs vest in three equal installments on the first, second and third anniversaries of July 1, 2026, contingent on her continued service.
The filing also notes a 1-for-10 reverse stock split effective at 12:01 AM on July 1, 2026, which reduced her share count and adjusted outstanding equity awards. Following the grant and split adjustment, she beneficially owns 31,240 shares of common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
TIMMINS MEGAN C.
Role
EVP, CLO & Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 15,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 31,240 shares (Direct)
Footnotes (1)
- Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries of July 1, 2026, subject to the Reporting Person's continued service to the Issuer. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Key Figures
RSU grant size: 15,000 shares
Post-transaction holdings: 31,240 shares
Reverse split ratio: 1-for-10
+2 more
5 metrics
RSU grant size
15,000 shares
Restricted stock units granted to EVP Megan C. Timmins
Post-transaction holdings
31,240 shares
Common stock beneficially owned following reported transaction(s)
Reverse split ratio
1-for-10
Reverse split of common stock effective July 1, 2026
Grant price per share
$0.0000 per share
Reported transaction price for RSU grant
Vesting schedule
3 equal installments
Vests on first, second and third anniversaries of July 1, 2026
Key Terms
Restricted stock units ("RSUs"), reverse split, equity awards, beneficially owned
4 terms
Restricted stock units ("RSUs") financial
"Restricted stock units ("RSUs") vest in three equal installments on the first, second and third anniversaries"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
equity awards financial
"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
beneficially owned financial
"the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s)"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
What insider transaction did Rockwell Medical (RMTI) report for Megan C. Timmins?
Rockwell Medical reported that EVP, CLO & Secretary Megan C. Timmins received a grant of 15,000 restricted stock units. These RSUs are in the form of common stock and were awarded at no cash cost as part of her equity-based compensation with the company.
What are the vesting terms of the 15,000 RSUs granted by Rockwell Medical (RMTI)?
The 15,000 RSUs granted to Megan C. Timmins vest in three equal installments. Vesting occurs on the first, second and third anniversaries of July 1, 2026, and each installment requires her continued service to Rockwell Medical through the applicable vesting date.
How did Rockwell Medical’s 1-for-10 reverse split affect insider holdings?
Rockwell Medical implemented a 1-for-10 reverse split effective at 12:01 AM on July 1, 2026. This reduced the number of shares held by Megan C. Timmins and triggered proportionate adjustments to outstanding equity awards, including the share balance reported following the Form 4 transaction.
Was the Rockwell Medical (RMTI) insider grant an open-market stock purchase?
No, the transaction was a grant of 15,000 restricted stock units, not an open-market purchase. The Form 4 categorizes it as a grant, award, or other acquisition, with a reported price per share of $0.0000, indicating compensation rather than a cash-funded buy.
What role does Megan C. Timmins hold at Rockwell Medical (RMTI)?
Megan C. Timmins serves as Executive Vice President, Chief Legal Officer and Secretary at Rockwell Medical. Her Form 4 filing reflects equity-based compensation tied to this leadership role, including the new restricted stock unit grant and adjusted post-split share ownership.